27. |
Share-based payments
The Bidvest Share Incentive Scheme (BIS) grants options and advances loans to employees of the Group to acquire shares in the Company. Both the share options
scheme and share purchase scheme have been classified as equity-settled schemes, and therefore an equity-settled share-based payment reserve has been
recognised.
The Bidvest Group Share Appreciation Rights (SARs) Plan was adopted to replaced the BIS, and has been classified as an equity-settled scheme, and therefore an
equity-settled share-based payment reserve has been recognised. Executive directors do not participate in the SARs Plan.
A conditional share plan (CSP), which awards executive directors with a conditional right to receive shares in the Company, free of any cost, is also operated by the
Group. As it is anticipated that the participants will receive shares in settlement of their awards, a share-based payment reserve has been recognised.
Replacement rights scheme (previously share option scheme)
Following the unbundling of Bidcorp, Bidvest option holders exchanged each one of their existing options for one right over one Bidcorp share and one Bidvest
share (replacement right). In terms of the amended scheme rules, the original option price was not adjusted, but on exercise of the replacement right, the original
option price will be deducted from the combined value of the Bidcorp share and the Bidvest share. The vesting date and lapse dates of the replacement rights will
be the same as those of the original options.
The terms and conditions of the replacement rights are:
Replacement right holders are only entitled to exercise their rights if they are in the employment of the Group in accordance with the terms referred to hereafter,
unless otherwise recommended by the board of the Company to the trustees of The Bidvest Share Incentive Trust.
Replacement right holders may exercise the rights at such times as the right holder deems fit, but not so as to result in the following proportions of the holder’s
total number of instruments being purchased prior to: 50% of total number of instruments at the expiry of three years; 75% of total number of instruments at the
expiry of four years; and 100% of total number of instruments at the expiry of five years from the date of the holder’s acceptance of an option. All rights must be
exercised no later than the 10th anniversary on which the original options were granted unless approval is obtained from the trustees of The Bidvest Share
Incentive Trust.
The number and weighted average exercise prices of replacement rights are:
| |
2017 |
|
|
2016 |
|
| |
Number |
Average
price
R |
|
|
Number |
Average
price
R |
|
| Beginning of year |
6 751 951 |
233,00 |
|
|
11 331 766 |
199,62 |
|
| Granted |
– |
– |
|
|
2 291 125 |
301,54 |
|
| Lapsed |
(244 858) |
251,15 |
|
|
(654 956) |
221,91 |
|
| Exercised |
(1 408 696) |
178,96 |
|
|
(3 020 509) |
161,90 |
|
| Transfer on unbundling |
– |
– |
|
|
(3 195 475) |
233,25 |
|
| End of year |
5 098 397 |
247,06 |
|
|
6 751 951 |
233,00 |
|
| The replacement rights outstanding at 30 June 2017 have an exercise price in the range of R100,00 to R301,54 (2016: R51,51 to R301,54)
and a weighted average contractual life of 1,3 to 8,4 (2016: 0,3 to 9,5)
years. The average combined value of the Bidvest and Bidcorp shares
during the year was R424,51 (2016: R354,36). |
|
|
|
|
|
|
|
| Replacement rights outstanding at 30 June by year of grant are: |
|
|
|
|
|
|
|
| 2006 |
– |
– |
|
|
120 000 |
61,75 |
|
| 2009 |
1 500 |
100,00 |
|
|
11 500 |
100,00 |
|
| 2011 |
149 290 |
135,00 |
|
|
196 215 |
135,00 |
|
| 2012 |
273 000 |
134,56 |
|
|
733 000 |
134,80 |
|
| 2013 |
613 938 |
208,91 |
|
|
932 250 |
208,91 |
|
| 2014 |
1 308 524 |
235,63 |
|
|
1 850 164 |
235,47 |
|
| 2015 |
1 312 620 |
252,85 |
|
|
1 400 197 |
252,82 |
|
| 2016 |
1 439 525 |
301,54 |
|
|
1 508 625 |
301,54 |
|
| |
5 098 397 |
247,06 |
|
|
6 751 951 |
233,00 |
|
The fair value of services received in return for shares allotted is measured based on a binomial model. The contractual life of the replacement right is used as an
input into this model.
The fair value of the replacement rights allotted during the current year and the assumptions used are:
| |
2017 |
|
2016 |
|
| Fair value at measurement date (Rand) |
– |
|
86,12 |
|
| Exercise price (Rand) |
– |
|
301,54 |
|
| Expected volatility (%) |
– |
|
23,78 |
|
| Option life (years) |
– |
|
4,00 – 6,00 |
|
| Distribution yield (%) |
– |
|
3,06 |
|
| Risk-free interest rate (based on National Government Bonds) (%) |
– |
|
9,21 |
|
SARs Plan
The terms and conditions of the SARs Plan are:
SAR holders are only entitled to exercise their rights if they are in the employment of the Group in accordance with the terms referred to hereafter, unless
otherwise recommended by the board of the Company to the trustees of The Bidvest Share Incentive Trust.
SAR holders in the scheme may exercise the SARs at such times as the holder deems fit, but not so as to result in the following proportions of the holder’s total
number of instruments being purchased prior to: 50% of total number of instruments at the expiry of three years; 75% of total number of instruments at the expiry
of four years; and 100% of total number of instruments at the expiry of five years from the date of the holder’s acceptance of an appreciation right. All SARs must
be exercised no later than the seventh anniversary on which they were granted unless approval is obtained from the trustees of The Bidvest Share Incentive Trust.
The number and weighted average exercise prices of share appreciation rights are:
| |
2017 |
|
|
2016 |
|
| |
Number |
Average
price
R |
|
|
Number |
Average
price
R |
|
| Beginning of year |
– |
– |
|
|
– |
– |
|
| Granted |
3 600 000 |
146,55 |
|
|
– |
– |
|
| Lapsed |
(15 000) |
146,61 |
|
|
– |
– |
|
| Exercised |
– |
– |
|
|
– |
– |
|
| End of year |
3 585 000 |
146,55 |
|
|
– |
– |
|
| SARs outstanding at 30 June by year of grant are: |
|
|
|
|
|
|
|
| 2017 |
3 585 000 |
146,55 |
|
|
– |
– |
|
| |
3 585 000 |
146,55 |
|
|
– |
– |
|
The SARs outstanding at 30 June 2017 have an exercise price in the range of R138,48 to R146,61 and a weighted average contractual life of 6,4 to 6,8 years.
The average value of the Bidvest share during the year was R160,89.
The fair value of services received in return for shares allotted is measured based on a binomial model. The contractual life of the SARs Plan is used as an input
into this model.
The fair value of the SARs allotted during the current year and the assumptions used are:
| |
2017 |
|
2016 |
|
| Fair value at measurement date (Rand) |
162,90 |
|
– |
|
| Exercise price (Rand) |
146,61 |
|
|
|
| Expected volatility (%) |
27,84 |
|
– |
|
| Option life (years) |
4,00 – 6,00 |
|
– |
|
| Distribution yield (%) |
2,78 |
|
– |
|
| Risk-free interest rate (based on the ZAR bond static yield curve) (%) |
7,77 |
|
– |
|
The volatility is based on the recent historic volatility.
Share purchase scheme
In terms of the share purchase scheme, the scheme advances loans to employees to acquire shares in the Company. Interest is charged on the loans at interest
rates determined by the board of directors of the Company, the loans must be settled no later than the 10th anniversary on which the shares were allotted and the
shares are held by the scheme as security for the loans.
The employees are entitled to settle the loans at such times as they deem fit, but not so as to result in the following proportions of the employees’ total number of
allotted shares being paid for prior to: 50% of total number of allotted shares at the expiry of three years; 75% of total number of allotted shares at the expiry of
four years; and 100% of total number of allotted shares at the expiry of five years from the date of the holder’s acceptance of the allotted share, unless otherwise
determined by the board of directors.
In terms of the unbundling, participants received one Bidcorp share for every Bidvest share they held. The Bidcorp shares are subject to the same terms and
conditions as the Bidvest shares in terms of the scheme.
Distributions arising on the allotted shares are utilised to settle any interest or income tax obligations with any excess being applied to settle the outstanding liability.
The number and weighted average exercise prices of shares allotted in terms of the share purchase scheme are:
| |
2017 |
|
|
2016 |
|
| |
Number |
Average
price
R |
|
|
Number |
Average
price
R |
|
| Beginning of year |
222 580 |
89,94 |
|
|
542 140 |
92,98 |
|
| Shares taken up by staff |
(222 580) |
87,50 |
|
|
(319 560) |
95,10 |
|
| End of year |
– |
0,00 |
|
|
222 580 |
89,94 |
|
Conditional share plan
In terms of the CSP scheme, a conditional right to a share is awarded to employees subject to performance and vesting conditions. The vesting period is as
follows: 75% of total number of awards vest at the expiry of three years; and 25% of total number of awards vest at the expiry of four years from the date of the
award, unless otherwise determined by the board. These share awards do not carry voting rights attributable to ordinary shareholders.
The fair value of services received in return for the conditional share awards has been determined by multiplying the number of conditional share awards expected
to vest by the share price at the date of the award less discounted by anticipated future distribution flows. A total number of 117 120 (2016: 26 131) of the
256 280 shares (2016: 35 000) are expected to vest, taking into account the performance of the Group to date and forecasts to the end of the performance
period, against the targets set at the time of the award. The average discounted share price used in the calculation of the share-based payment charge on the
conditional share awards allotted during the year is R122,78 (2016: R273,91) per share. These awards will vest in the next three years.
As a result of the unbundling, the 2015 awards were restructured into replacement conditional rights (replacement right) in the successor companies – ie each
conditional right in terms of the 2015 awards was exchanged for a replacement right over either a Bidvest share or a Bidcorp share, depending on which
successor company the participant was employed. On 24 October 2016, 35 000 original conditional share awards were exchanged for 94 280 replacement
conditional rights over Bidvest shares.
The Group will continue to use the existing CSP for new awards to its executive directors, and the CSP rules will regulate the replacement rights received as a
result of the unbundling.
There were no conditional share awards (2016: 173 755) forfeited as a result of performance conditions not being met.
The number of conditional share awards in terms of the conditional share award scheme are:
| |
2017
Number |
|
2016
Number |
|
| Beginning of year |
35 000 |
|
742 029 |
|
| Allotted during the year |
256 280 |
|
159 000 |
|
| Awarded during the year |
– |
|
(241 061) |
|
| Awarded during the year as a result of accelerated vesting |
– |
|
(327 213) |
|
| Forfeited during the year |
– |
|
(173 755) |
|
| Exchanged for replacement rights |
(35 000) |
|
– |
|
| Transfer on unbundling |
– |
|
(124 000) |
|
| End of year |
256 280 |
|
35 000 |
|
Following the adoption of the SARs Plan, the maximum number of shares which may be allocated at any one time under the SARs Plan and existing CSP shall not
exceed 16 750 000 shares (5% of shares in issue). A total of 12 908 720 shares remain available for allocation.
Other equity-settled share-based payment schemes
Bidvest Namibia Limited, a subsidiary, also operates its own share option scheme, the expense of which has been included in the consolidated income statement
and the resulting reserve in the consolidated share-based payment reserve in equity. Details as to how this expense has been calculated have not been included
above, but are published in the annual integrated report of Bidvest Namibia Limited, which can be found at www.bidvest.com.na. |